A detailed history of State Board Of Administration Of Florida Retirement System transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 129,417 shares of ALNY stock, worth $32.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
129,417
Previous 135,347 4.38%
Holding current value
$32.9 Million
Previous $32.9 Million 8.24%
% of portfolio
0.07%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$233.81 - $287.01 $1.39 Million - $1.7 Million
-5,930 Reduced 4.38%
129,417 $35.6 Million
Q2 2024

Aug 08, 2024

SELL
$143.31 - $247.0 $240,044 - $413,725
-1,675 Reduced 1.22%
135,347 $32.9 Million
Q1 2024

May 08, 2024

BUY
$146.51 - $198.2 $166,288 - $224,957
1,135 Added 0.84%
137,022 $20.5 Million
Q4 2023

Feb 09, 2024

BUY
$151.41 - $196.57 $708,144 - $919,357
4,677 Added 3.56%
135,887 $26 Million
Q3 2023

Nov 08, 2023

SELL
$170.77 - $211.65 $913,619 - $1.13 Million
-5,350 Reduced 3.92%
131,210 $23.2 Million
Q2 2023

Aug 11, 2023

SELL
$185.01 - $212.05 $85,474 - $97,967
-462 Reduced 0.34%
136,560 $25.9 Million
Q1 2023

Jun 14, 2023

SELL
$182.66 - $235.53 $1,826 - $2,355
-10 Reduced 0.01%
137,022 $27.4 Million
Q1 2023

May 11, 2023

SELL
$182.66 - $235.53 $1,826 - $2,355
-10 Reduced 0.01%
137,022 $27.4 Million
Q4 2022

Jun 14, 2023

BUY
$185.53 - $241.31 $1,855 - $2,413
10 Added 0.01%
137,032 $32.6 Million
Q4 2022

Feb 07, 2023

SELL
$185.53 - $241.31 $326,532 - $424,705
-1,760 Reduced 1.27%
137,032 $32.6 Million
Q3 2022

Nov 08, 2022

BUY
$138.54 - $232.0 $27,015 - $45,240
195 Added 0.14%
138,792 $27.8 Million
Q2 2022

Aug 05, 2022

SELL
$120.42 - $169.29 $773,337 - $1.09 Million
-6,422 Reduced 4.43%
138,597 $20.2 Million
Q1 2022

May 06, 2022

SELL
$127.18 - $173.91 $378,233 - $517,208
-2,974 Reduced 2.01%
145,019 $23.7 Million
Q4 2021

Feb 08, 2022

SELL
$159.56 - $209.29 $333,639 - $437,625
-2,091 Reduced 1.39%
147,993 $25.1 Million
Q3 2021

Nov 08, 2021

SELL
$169.75 - $207.73 $473,263 - $579,151
-2,788 Reduced 1.82%
150,084 $28.3 Million
Q2 2021

Aug 10, 2021

SELL
$128.63 - $176.89 $244,911 - $336,798
-1,904 Reduced 1.23%
152,872 $25.9 Million
Q1 2021

May 10, 2021

SELL
$126.83 - $175.69 $691,223 - $957,510
-5,450 Reduced 3.4%
154,776 $21.9 Million
Q4 2020

Feb 08, 2021

BUY
$122.97 - $147.0 $1.18 Million - $1.41 Million
9,617 Added 6.39%
160,226 $20.8 Million
Q3 2020

Nov 09, 2020

BUY
$121.19 - $165.49 $359,934 - $491,505
2,970 Added 2.01%
150,609 $21.9 Million
Q2 2020

Aug 07, 2020

BUY
$104.21 - $156.44 $379,115 - $569,128
3,638 Added 2.53%
147,639 $21.9 Million
Q1 2020

May 05, 2020

BUY
$93.12 - $133.99 $440,643 - $634,040
4,732 Added 3.4%
144,001 $15.7 Million
Q4 2019

Feb 03, 2020

BUY
$74.51 - $124.23 $207,584 - $346,104
2,786 Added 2.04%
139,269 $16 Million
Q3 2019

Nov 07, 2019

BUY
$70.9 - $87.82 $234,679 - $290,684
3,310 Added 2.49%
136,483 $11 Million
Q2 2019

Aug 05, 2019

BUY
$65.86 - $92.79 $529,185 - $745,567
8,035 Added 6.42%
133,173 $9.66 Million
Q1 2019

May 03, 2019

SELL
$72.76 - $93.45 $40,018 - $51,397
-550 Reduced 0.44%
125,138 $11.7 Million
Q4 2018

Feb 01, 2019

BUY
$62.67 - $88.33 $363,486 - $512,314
5,800 Added 4.84%
125,688 $9.16 Million
Q3 2018

Oct 31, 2018

SELL
$87.52 - $122.67 $44,460 - $62,316
-508 Reduced 0.42%
119,888 $10.5 Million
Q2 2018

Aug 06, 2018

BUY
$88.31 - $107.8 $226,956 - $277,046
2,570 Added 2.18%
120,396 $11.9 Million
Q1 2018

May 04, 2018

BUY
$115.92 - $148.54 $186,167 - $238,555
1,606 Added 1.38%
117,826 $14 Million
Q4 2017

Feb 01, 2018

BUY
$114.49 - $139.98 $832,571 - $1.02 Million
7,272 Added 6.67%
116,220 $14.8 Million
Q3 2017

Oct 31, 2017

BUY
$72.53 - $118.27 $7.9 Million - $12.9 Million
108,948
108,948 $12.8 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.